201 related articles for article (PubMed ID: 3422828)
1. Complete remission in acute promyelocytic leukemia despite persistence of abnormal bone marrow promyelocytes during induction therapy: experience in 34 patients.
Stone RM; Maguire M; Goldberg MA; Antin JH; Rosenthal DS; Mayer RJ
Blood; 1988 Mar; 71(3):690-6. PubMed ID: 3422828
[TBL] [Abstract][Full Text] [Related]
2. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
3. A complete remission can be achieved despite persistence of abnormal bone marrow promyelocytes in acute promyelocytic leukemia--experience in 2 patients.
Kim SW; Lee KH; Lee JS; Suh C; Ahn MJ; Kim SW; Chi HS; Kim SH
J Korean Med Sci; 1993 Aug; 8(4):246-50. PubMed ID: 8198760
[TBL] [Abstract][Full Text] [Related]
4. [The curative treatment of adult acute nonlymphocytic leukemia].
Uzuka Y; Saito Y
Rinsho Ketsueki; 1989 Aug; 30(8):1163-6. PubMed ID: 2601025
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow morphology during induction phase of therapy for acute myeloid leukemia (AML).
Dick FR; Burns CP; Weiner GJ; Heckman KD
Hematol Pathol; 1995; 9(2):95-106. PubMed ID: 7559259
[TBL] [Abstract][Full Text] [Related]
6. Adult acute leukemia.
Cripe LD
Curr Probl Cancer; 1997; 21(1):1-64. PubMed ID: 9058027
[TBL] [Abstract][Full Text] [Related]
7. Acute promyelocytic leukemia is a distinct subset of acute myelocytic leukemia with unique clinicopathologic characteristics including longer duration of relapse free survival: experience in 13 cases.
Lee KH; Kim DH; Lee JS; Suh CW; Kim SW; Kim SB; Lee JH; Doh BS; Chi HS; Lee MS
J Korean Med Sci; 1994 Dec; 9(6):437-43. PubMed ID: 7786438
[TBL] [Abstract][Full Text] [Related]
8. Induction therapy of newly diagnosed acute nonlymphocytic leukemia with idarubicin and cytosine arabinoside--the Taiwan experience.
Chen YC; Lin SF; Yao M; Chen TY; Tsao CJ; Chen TP
Semin Hematol; 1996 Oct; 33(4 Suppl 3):30-4. PubMed ID: 8916314
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of blood and marrow findings in acute myelogenous leukemia in remission. A Southeastern Cancer Study Group report.
Vogler WR; Raney MR
Cancer; 1988 Jun; 61(12):2481-6. PubMed ID: 3163256
[TBL] [Abstract][Full Text] [Related]
10. Teniposide (VM-26) and continuous infusion cytosine arabinoside for initial induction failure in childhood acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
Ochs J; Rivera GK; Pollock BH; Buchanan G; Crist W; Freeman AI
Cancer; 1990 Oct; 66(8):1671-7. PubMed ID: 2208021
[TBL] [Abstract][Full Text] [Related]
11. Acute promyelocytic leukemia. M.D. Anderson Hospital experience.
Kantarjian HM; Keating MJ; Walters RS; Estey EH; McCredie KB; Smith TL; Dalton WT; Cork A; Trujillo JM; Freireich EJ
Am J Med; 1986 May; 80(5):789-97. PubMed ID: 3458366
[TBL] [Abstract][Full Text] [Related]
12. Acute myeloid leukemia in Manitoba. The consequences of standard "7 + 3" remission-induction therapy followed by high dose cytarabine postremission consolidation for myelosuppression, infectious morbidity, and outcome.
Bow EJ; Kilpatrick MG; Scott BA; Clinch JJ; Cheang MS
Cancer; 1994 Jul; 74(1):52-60. PubMed ID: 8004583
[TBL] [Abstract][Full Text] [Related]
13. A characteristic pattern of leukemic cell differentiation without cytoreduction during remission induction in acute promyelocytic leukemia.
Kantarjian HM; Keating MJ; McCredie KB; Beran M; Walters R; Dalton WT; Hittleman W; Freireich EJ
J Clin Oncol; 1985 Jun; 3(6):793-8. PubMed ID: 3859586
[TBL] [Abstract][Full Text] [Related]
14. Residual leukemic cell counts in the bone marrow at the end point of intensive induction therapy may be a prognostic factor for acute myeloblastic leukemia in adults.
Fujisawa S; Maruta A; Motomura S; Fukawa H; Kanamori H; Ogawa K; Matsuzaki M; Miyashita H; Harano H; Murata T; Sakai R; Mohri H; Kodama F; Okubo T
Leuk Lymphoma; 1998 Mar; 29(1-2):161-70. PubMed ID: 9638985
[TBL] [Abstract][Full Text] [Related]
15. Intermediate and high dose Ara-C and m-AMSA for remission induction and consolidation treatment of patients with acute myeloid leukemia: an EORTC Leukemia Cooperative Group phase II study.
Willemze R; Jager U; Jehn U; Stryckmans P; Bury J; Suciu S; Solbu G; Zittoun R; Burghouts J; Löwenberg B
Eur J Cancer Clin Oncol; 1988 Nov; 24(11):1721-5. PubMed ID: 3061827
[TBL] [Abstract][Full Text] [Related]
16. Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group.
Arlin Z; Case DC; Moore J; Wiernik P; Feldman E; Saletan S; Desai P; Sia L; Cartwright K
Leukemia; 1990 Mar; 4(3):177-83. PubMed ID: 2179638
[TBL] [Abstract][Full Text] [Related]
17. [Complete remission without marrow aplasia phase in a patient with acute promyelocytic leukosis treated with aggressive chemotherapy].
del Potro Gómez E; Martínez Martínez R; López Martín JC; Díaz Morfa M; Díaz Mediavilla J; Espinos Pérez D
An Med Interna; 1989 May; 6(5):255-6. PubMed ID: 2491539
[TBL] [Abstract][Full Text] [Related]
18. Complete remission in acute promyelocytic leukemia despite the persistence of the 15;17 translocation.
Wallace PJ
Am J Hematol; 1989 Aug; 31(4):266-8. PubMed ID: 2741926
[TBL] [Abstract][Full Text] [Related]
19. Busulfan/etoposide--initial experience with a new preparatory regimen for autologous bone marrow transplantation in patients with acute nonlymphoblastic leukemia.
Chao NJ; Stein AS; Long GD; Negrin RS; Amylon MD; Wong RM; Forman SJ; Blume KG
Blood; 1993 Jan; 81(2):319-23. PubMed ID: 8422458
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of day 15 blast clearance in risk-adapted remission induction chemotherapy for younger patients with acute myeloid leukemia: long-term results of the multicenter prospective LAM-2001 trial by the GOELAMS study group.
Bertoli S; Bories P; Béné MC; Daliphard S; Lioure B; Pigneux A; Vey N; Delaunay J; Leymarie V; Luquet I; Blanchet O; Cornillet-Lefebvre P; Hunault M; Bouscary D; Fegueux N; Guardiola P; Dreyfus F; Harousseau JL; Cahn JY; Ifrah N; Récher C;
Haematologica; 2014 Jan; 99(1):46-53. PubMed ID: 23975179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
